EUVIMEDEUVIMED entdecken
Crossref

In Vitro Assessment of Novel Ciprofloxacin Derivative Effects on Cell Proliferation, Cell Cycle and Oxidative Stress–Induced Apoptosis in Chronic Myeloid Leukemia K562 Cell Line

Raziyeh Barzegari, Mehdi Mohammadzadeh iD, Majid Mahdavi iD

Journal of Applied Toxicology · 2026-12 · 46 (12) · 4636-4645

DOI: 10.1002/jat.70151 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Applied Toxicology, online erschienen am 30.04.2026. Verfasst von Raziyeh Barzegari und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Faculty of Sciences, Urmia University, Urmia, Iran. Hauptthemen laut MEDLINE: Apoptosis, Ciprofloxacin, Cell Proliferation, Oxidative Stress. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ciprofloxacin (CP) is an antibiotic that exhibits notable antiproliferative effects on various types of cancer cells. This study evaluated the effects of a new synthetic derivative of CP on proliferation, viability, and apoptosis induction in human leukemia K562 cells. To this end, K562 cells were exposed to different concentrations (5–50 μM) of the new compound for 24, 48, and 72 h. Cell viability, cell growth, cell apoptosis induction, cell cycle, and the production of intracellular reactive oxygen species (ROS) were assessed using the MTT method, Hoechst 33258 staining, Annexin V/PI double‐staining flow cytometry, and DCFH‐DA staining, respectively. Moreover, real‐time PCR technique was employed to investigate the expression of Bax and Bcl‐2 genes. Results revealed that the new compound inhibited cell viability and growth in a dose‐ and time‐dependent manner, with an IC 50 of 10 μM for 72 h. The 4‐IPMCP treatment induced apoptosis in K562 cells by down‐regulating Bcl‐2, overexpressing Bax, and increasing the Bax/Bcl‐2 ratio. This treatment also stimulated cellular ROS generation and induced cell cycle arrest in the sub‐G1 phase. This study demonstrated the effects of 4‐IPMCP on cell cycle arrest, anticancer properties, and oxidative stress–induced apoptosis in chronic myeloid leukemia (CML) K562 cells. Since this agent has the potential to inactivate cancer cells and treat patients, it can be considered a viable candidate for further drug studies in cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApoptosisCiprofloxacinCell ProliferationOxidative StressLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCell CycleAntineoplastic AgentsHumansK562 CellsReactive Oxygen SpeciesCell SurvivalDose-Response Relationship, DrugProto-Oncogene Proteins c-bcl-2

Stichwörter der Autor:innen

K562 cell lineROSapoptosiscell cyclechronic myeloid leukemiaciprofloxacin derivative

Substanzen

CiprofloxacinReactive Oxygen SpeciesAntineoplastic AgentsProto-Oncogene Proteins c-bcl-2

Autor:innen und Institutionen

  • Department of Biology, Faculty of Sciences, Urmia University, Urmia, Iran.
  • Department of Biochemistry, Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran, Iran.

ORCID-Profile: Mehdi Mohammadzadeh, Majid Mahdavi

Zitieren

APA

Barzegari, R., Mohammadzadeh, M., & Mahdavi, M. (2026). In Vitro Assessment of Novel Ciprofloxacin Derivative Effects on Cell Proliferation, Cell Cycle and Oxidative Stress–Induced Apoptosis in Chronic Myeloid Leukemia K562 Cell Line. Journal of Applied Toxicology, 46(12), 4636-4645. https://doi.org/10.1002/jat.70151

Vancouver

Barzegari R, Mohammadzadeh M, Mahdavi M. In Vitro Assessment of Novel Ciprofloxacin Derivative Effects on Cell Proliferation, Cell Cycle and Oxidative Stress–Induced Apoptosis in Chronic Myeloid Leukemia K562 Cell Line. Journal of Applied Toxicology. 2026;46(12):4636-4645. doi:10.1002/jat.70151

BibTeX
@article{Barzegari2026,
  author = {Barzegari, Raziyeh and Mohammadzadeh, Mehdi and Mahdavi, Majid},
  title = {In Vitro Assessment of Novel Ciprofloxacin Derivative Effects on Cell Proliferation, Cell Cycle and Oxidative Stress–Induced Apoptosis in Chronic Myeloid Leukemia K562 Cell Line},
  journal = {Journal of Applied Toxicology},
  year = {2026},
  volume = {46},
  number = {12},
  pages = {4636--4645},
  doi = {10.1002/jat.70151}
}
Kostenlos starten →